Pharmacy is a four-year undergraduate course that deals with the production, properties, use and effects of medicinal drugs. Those who complete this course can pursue careers in pharmaceutical industry, medical research, hospitals, manufacturing units and more.

pharmacy course:

Let’s look at some key details of the pharmacy course:

B Pharmacy Full Form

Full Form – The full form of pharmacy is Bachelor of Pharmacy (B.Pharma).

B Pharmacy Duration

Duration – B.Pharma is a 4 year undergraduate degree program.

 

B Pharmacy Eligibility

Eligibility – To take admission in B.Pharma, the candidate must have passed 10+2 or equivalent exam with Physics, Chemistry and Biology as main subjects, securing at least 45% (40% for reserved categories) marks.

B Pharmacy Admission Process

– Admission is given on the basis of marks obtained in qualifying exam and entrance exam. Popular entrance exams are NEET MDS, PET, AUAT etc.

b pharmacy Fee Structure

– The average annual fee of B.Pharma program in a government college ranges from Rs.15,000-30,000 whereas in a private college it is Rs.60,000-1,00,000 per annum. Hostel and mess charges are additional.

Career Prospects –

After completing B.Pharma, one can work as a pharmacist, medical representative, quality control analyst, production manager, research & development scientist and more. One can also do M.Pharma and PhD to teach or do research.

top pharmacy college in meerut

Now, coming to  best pharmacy colleges in Meerut, here are some top options:

Venkateshwara Group of institutions – Established in 1998, this is one of the oldest and top pharmacy colleges in Meerut known for quality education and high placement record.

The Joint Entrance Examination Council, Uttar Pradesh (JEECUP) has released the JEECUP Admit Card 2024 on May 28, 2024, for the upcoming UP Polytechnic examination. Here is a detailed guide on how to download the JEECUP Admit Card 2024 JEECUP Admit Card 2024 for Admission in Top  b pharma college in meerut :

Steps to Download JEECUP Admit Card 2024

  1. Visit the Official Website: Go to the official website of JEECUP at best pharmacy colllege in Up
  2. Click on the Download Link: Click on the link “Download Admit Card for Joint Entrance Examination (Polytechnic) 2024” under the Candidate Activity Board based on the group (A, E1, E2, B, K1, K8) you registered for
  3. Log In with Credentials: Enter your JEECUP 2024 Application Number, Password, and Security PIN
  4. Verify OTP: Enter the OTP sent to your registered Mobile Number or Email ID
  5. Download and Print: Once you have successfully logged in, your JEECUP Admit Card 2024 will appear on the screen. Download and take a printout of it for further use

Details Mentioned on JEECUP Admit Card 2024

  • Name of the Candidate
  • UPJEE 2024 Roll Number
  • Registration Number
  • Father’s Name
  • Mother’s Name
  • Medium of exam
  • Subject Name
  • Subject Code
  • School Name
  • JEECUP exam date and time
  • Details of JEECUP exam centre 2024
  • Name and Address of the Examination Center
  • Candidate’s date of birth
  • Photograph (uploaded at the time of application form)
  • Signature of the candidate
  • Exam instructions that are to be followed on the examination day.

Forgot Password?

If you forget your password, you can reset it using the following steps:

  1. Visit the Official Website: Go to the official website of JEECUP at
  2. Click on the Forgot Password Link : Click on the “Forgot Password” link to the right of the Sign in button
  3. Reset Password: You will be provided with two options to reset your password: using an OTP sent via SMS or using a reset link sent via email. Follow the instructions to reset your password

Active Pharmaceutical Ingredients and High Potency API Industry Data Book | Forecast 2030

Active Pharmaceutical Ingredients and High Potency API Industry Data Book – Active Pharmaceutical Ingredients and High Potency Active Pharmaceutical Ingredients Market

Grand View Research’s API and High Potency API industry databook is a collection of market sizing & forecasts insights, regulatory & technology framework, pricing intelligence, competitive benchmarking analyses, macro-environmental analyses studies. Within the purview of the database, such information is systematically analyzed and provided in the form of summary presentations and detailed outlook reports on individual areas of research.The following data points will be included in the final product offering in two reports and one sector report overview.

 

Access the Global Active Pharmaceutical Ingredients and High Potency API Industry Data Book, 2023 to 2030, compiled with details like market sizing information & forecasts, trade data, pricing intelligence, competitive benchmarking, macro-environmental analyses, and regulatory & technological framework studies

 

Active Pharmaceutical Ingredients Market Report Highlights

  • Innovative APIs held the largest share of 47.07% in 2022, owing to increasing research and development activities for novel drug development and positive government initiatives

 

  • The cardiovascular disease segment held the largest revenue share of 21.54% in 2022, attributed to the rising prevalence of target disease globally

 

  • The synthetic API segment dominated the market with the largest revenue share of 72.6% in 2021, owing to the higher availability of raw materials and easier protocols for the synthesis of these molecules

 

  • North America accounted for the largest revenue share of 38.80% in 2021 and is expected to maintain its lead over the forecast period. This is attributed to the rising epidemiology of cancer, along with other lifestyle-induced diseases, thus encouraging the R&D activities, thereby boosting the market growth

 

 

Order your copy of the Free Sample of “Active Pharmaceutical Ingredients and High Potency API Industry Data Book – Active Pharmaceutical Ingredients and High Potency Active Pharmaceutical Ingredients Market Size, Share, Trends Analysis, And Segment Forecasts, 2023 – 2030, published by Grand View Research

 

High Potency Active Pharmaceutical Ingredients Market

 

  • In 2022, synthetic segment held a dominant share in the HPAPI market owing to its easier synthesis and effectiveness in treatment offered by synthetic HPAPI

 

  • Outsourced segment is projected to grow at the fastest rate over the forecast period owing to the increasing adoption of outsourcing of HPAPI

 

  • Innovative HPAPI segment is the highest revenue-generating segment in 2022 owing to the increased focus on R&D.

 

  • Oncology segment dominated the overall market owing to the rising cancer incidence worldwide along with an enhanced focus on targeted therapies

 

  • Asia Pacific is expected to witness the fastest growth during the forecast period owing to the improved manufacturing facilities and the availability of many generic HPAPI producers

 

Competitive Landscape

 

Competitive rivalry in this market is likely to be high due to increasing interest in small molecules and biologics for the treatment of chronic diseases is attracting industry players. These players have adopted strategies such as acquisitions, collaborations, and expansion of manufacturing units to strengthen their position in the market. Development of targeted therapies over the forecast period is expected to further intensify the competitive rivalry in the market. As part of strategic geographical expansion, many companies are setting up manufacturing plants in Asia Pacific region. In addition, increasing number of companies switch to contract manufacturers for APIs, which is further increasing competitive rivalry.

 

Some of the key players in the API and High Potency API market are Teva Pharmaceutical Industries Ltd., AbbVie, Inc., BASF SE, Boehringer Ingelheim International GmbH, CordenPharma, Merck & Co., Inc., Dr. Reddy’s Laboratories Ltd., Cipla, Inc., Bristol-Myers Squibb Company, Sun Pharmaceutical Industries Ltd., Sanofi, Pfizer, Inc., Viatris Inc., Albemarle Corporation, and Aurobindo Pharma.

 

Key market players adopting expansion strategy include Novo Nordisk, Merck KGaA, Novartis AG, Aurobindo Pharma, and Piramal Pharma. For instance, in November 2022, Novo Nordisk Invested USD 744 million for expansion of its clinical manufacturing facility in Bagsvaerd, Denmark. This strategy is adopted to increase the outreach of their products in the market and increase the availability of their products & services in diverse geographical areas.

 

© 2024 Crivva. All Rights Reserved.